A special system to promote patient relaxation during proton treatments enables them to select comforting light, sound and images for the treatment room before their therapy begins, thus transforming a cold, impersonal environment into a tailor-made and far pleasanter environment.
In their first active collaboration, the Belgian firm IBA Group, which produces advanced cancer diagnosis and therapy technologies, and Royal Philips Electronics will install a state-of-the-art, patient-centred proton therapy treatment room in the Willis-Knighton Cancer Centre in Shreveport, Louisiana, USA, will be the first IBA installation to incorporate the Philips Ambient Experience, designed and engineered by Philips Healthcare.
Olivier Legrain, IBA CEO said that the Philips-IBA cooperative agreement demonstrates a successful collaboration in offering highly advanced, patient-centred care, a statement backed up by Dr Lane Rosen, at the Willis-Knighton Cancer Centre, who observed: ‘Ambient Experience enhances our ability to provide superior cancer care. The soothing and empowering atmosphere will make our patients more comfortable, which will allow our staff to work more efficiently.’
This will be the first centre to utilise ProteusONE, IBA’s single-room compact gantry solution for those needing a more cost-effective, smaller footprint option, the Belgian firm reports. The $40 million project is expected to begin proton treatments for cancer patients in early 2014.
*ProteusONE is the brand name of a new configuration of the Proteus 235, including some new developments subject to review by Competent Authorities (FDA, European Notified Bodies, et al.) before marketing.